Preferred Label : rimegepant;
Origin ID : M000646819;
Currated CISMeF NLP mapping
- Related record
https://www.cbip.be/fr/articles/4051?folia=4050
2023
false
false
false
Belgium
French
migraine disorders
journal article
rimegepant
rimegepant
---
https://www.ema.europa.eu/en/medicines/human/EPAR/vydura
2022
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
rimegepant
rimegepant
rimegepant
migraine with aura
migraine disorders
adult
Product containing precisely rimegepant (as rimegepant sulfate) 75 milligram/1 each
conventional release orodispersible tablet (clinical drug)
drug approval
europe
migraine without aura
administration, oral
receptors, calcitonin gene-related peptide
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
---
